gimli

GKSL stock AI analysis

GKSL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

GUJARAT KIDNEY N SUP SP L is a small-cap stock in Healthcare. This Gimli page shows the latest available GKSL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive GKSL stock page

Price

₹161.05

1W return

-7.63%

1M return

-17.10%

3M return

+26.08%

6M return

+28.61%

1Y return

n/a

Market cap

₹1,269.77 cr

79.16

4.98

ROE

+10.89%

ROCE

+10.83%

RSI

34.20

Turnover

₹9.63 cr

Why it can matter in screens

Momentum: GKSL is below 50DMA, above 200DMA; RSI is 34.20.
Returns: 1D -1.55%, 1W -7.63%, 1M -17.10%, 3M +26.08%, 1Y n/a.
Trend levels: 52W high ₹209.80, 52W low ₹122.24, off high -23.24%.
Liquidity: latest turnover is ₹9.63 cr; volume vs 20D is +0.88%.
Valuation/profitability: PE 79.16, PB 4.98, ROE +10.89%, ROCE +10.83%.
Growth: 3Y sales CAGR -1.49%, 3Y profit CAGR +32.65%.

Quick Answers

What is the latest GKSL stock price?

The latest stored price for GKSL is Rs 161.05 as of 2026-11-03.

Is GKSL above its 50DMA and 200DMA?

GKSL is below 50DMA, above 200DMA. The latest 50DMA is 174.62 and the latest 200DMA is 134.36.

What are GKSL PE, ROE and ROCE?

GKSL has PE 79.16, ROE +10.89%, and ROCE +10.83% in Gimli's latest available snapshot.

How has GKSL performed recently?

GKSL has returned -17.10% over 1 month, +26.08% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	34.29 cr	9.07 cr	5.18 cr	0.66
2026-03-31	30.58 cr	7.01 cr	5.04 cr	0.81
2025-12-31	23.25 cr	6.96 cr	2.94 cr	0.52
2025-09-30	13.02 cr	5.21 cr	2.88 cr	0.47
2025-06-30	31.09 cr	13.66 cr	7.80 cr	0.99
2025-03-31	9.78 cr	2.67 cr	1.28 cr	0.16
2024-12-31	11.79 cr	4.65 cr	2.50 cr	0.32

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	82.01 cr	27.81 cr	15.50 cr	2.49
2025-03-31	40.24 cr	16.70 cr	9.41 cr	1.19
2024-03-31	103.44 cr	22.03 cr	9.68 cr	1.23
2023-03-31	85.79 cr	17.93 cr	6.64 cr	0.84

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	297.64 cr	13.28 cr	29.11 cr	254.74 cr
2025-03-31	91.29 cr	4.58 cr	22.77 cr	39.83 cr
2024-03-31	65.40 cr	3.90 cr	27.34 cr	22.85 cr
2023-03-31	63.86 cr	1.90 cr	23.20 cr	22.30 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	-3.86 cr	-157.28 cr	n/a
2025-03-31	13.61 cr	-4.64 cr	n/a
2024-03-31	1.21 cr	1.21 cr	n/a
2023-03-31	0.00 cr	0.00 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+71.45%	+4.88%	+0.56%	+0.00%	+23.10%	+0.00%
2026-03-31	+71.45%	+4.88%	+0.56%	+0.00%	+23.10%	+0.00%
2025-12-31	+71.45%	+10.47%	+1.67%	+0.00%	+16.40%	+0.00%
2025-12-29	+71.45%	+13.09%	+7.84%	+0.00%	+7.62%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	424,658.30 cr	35.053345	+15.50%	+3.72%
DIVISLAB	DIVI S LABORATORIES LTD	267,167.60 cr	91.684145	+18.37%	+47.91%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,377.11 cr	74.094685	+16.87%	+28.16%
LAURUSLABS	LAURUS LABS LIMITED	125,408.69 cr	114.827348	+21.77%	+138.16%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	124,833.39 cr	27.818646	+16.04%	+26.46%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	121,354.29 cr	57.614911	+22.62%	+7.87%
DRREDDY	DR. REDDY S LABORATORIES	113,923.95 cr	40.698752	+7.80%	+14.41%
CIPLA	CIPLA LTD	112,841.65 cr	38.950805	+8.80%	-7.58%

Try these prompts

Analyze GUJARAT KIDNEY N SUP SP L with valuation, momentum and industry peers
Compare GKSL with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.